ArticleTurkish journal of ophthalmology2016

Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia.

Tuğba Aydoğan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.